Exchange: OTC·Updated 03:55 PM EDT

CVALF Covalon Technologies Ltd

$2.39
$0.18
(8.14%)
Today
Reported EarningsAug 27
Mkt Cap$61.04M
Vol112,546.00

About CVALF

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada.
49

Neutral Sentiment

How do you feel about CVALF?

Advertisement|Remove ads.